Vanilloid receptor 1 immunoreactivity in inflamed human bowel

Lancet

Volumn 357, Issue 9265, 2001, Pages 1338-1339

  Yiangou, Y ^a   Facer, P ^a   Dyer, N H C ^b   Chan, C L H ^c   Knowles, C ^c   Williams, N S ^c   Anand, P ^a  

^a IMPERIAL COLLEGE LONDON   (United Kingdom)

^b ROCHE BIOSCIENCE   (United States)

^c ST BARTHOLOMEW S HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

UNCLASSIFIED DRUG; VANILLOID RECEPTOR; VANILLOID RECEPTOR 1;

ARTICLE; COLON; CONTROLLED STUDY; DRUG DEVELOPMENT; DRUG RECEPTOR BINDING; ENTERITIS; HUMAN; HUMAN TISSUE; IMMUNOBLOTTING; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; INTESTINE MOTILITY; NERVE FIBER; PAIN; PRIORITY JOURNAL; RECEPTOR DENSITY;

EID: 0035962308     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(00)04503-7     Document Type: Article

References (5)

1. Caterina M.J., Leffler A., Malmberg A.B., et al. Impaired nociception and pain sensation in mice lacking the capsaicin receptor. Science. 288:2000;306-313.
2. Davis J.B., Gray J., Gunthorpe M.J., et al. Vanilloid receptor-1 is essential for inflammatory thermal hyperalgesia. Nature. 405:2000;183-187.
3. Baron R. Capsaicin and nociception: from basic mechanisms to novel drugs. Lancet. 356:2000;785-786.
4. Yiangou Y., Birch R., Sangameswaran L., Eglen R., Anand P. SNS/PN3 and SNS2/NaN sodium channel-like immunoreactivity in human adult and neonate injured sensory nerves. FEBS Lett. 467:2000;249-252.
5. Anand P., Terenghi G., Warner G., et al. The role of nervegrowth factor in human diabetic neuropathy. Nat Med. 2:1996;703-707.